Unresolved issues in Barrett's esophagus in the new millennium.
Falk
G
G
Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. falkg@ccf.org
D000230:Adenocarcinoma / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D001471:Barrett Esophagus / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D051546:Cyclooxygenase 2; D004564:Electrocoagulation; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D005764:Gastroesophageal Reflux / Q000150:complications; D006801:Humans; D016623:Ion Pumps / Q000037:antagonists & inhibitors; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008565:Membrane Proteins; D010544:Peroxidases / Q000037:antagonists & inhibitors; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D015995:Prevalence; D011451:Prostaglandin-Endoperoxide Synthases / Q000494:pharmacology; D012307:Risk Factors
D004791:Enzyme Inhibitors; D016623:Ion Pumps; D007527:Isoenzymes; D008565:Membrane Proteins; D017319:Photosensitizing Agents; D010544:Peroxidases; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases